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2 minor allele frequency (MAF) was compared to 1000 Genomes Project (GP) data for 174 Europeans (CEU/GBR, version 20110521) who were assumed unaffected by EOC. A Z-test for equal proportions was used to assess variants for association with EOC risk, and rank them according to p-value. Rather than select these variants based solely on extreme p-values, which may reflect sequence platform differences or the small sample size of the study, variants were placed in one of four categories based on MAF and each category was over-sampled. The four categories were: 1) MAF > 0 in serous EOC cases, monomorphic in 1000 GP ("EOC+"); 2) polymorphic in cases and 1000 GP, but MAF greater in cases ("EOC↑"); 3) polymorphic in cases and 1000 GP, but MAF less in cases ("EOC↓"); and 4) monomorphic in cases, MAF> 0 in 1000 GP ("EOC−"). In total, we selected the 1,800 custom variants from each category with the lowest p-values (7,200 in total) . After satisfying the Affymetrix probe design criteria, 7,189 variants were included on the array.
NF-B and endometrioid EOC GWAS variants
We included 1,170 variants in NF-B binding motifs that were validated or predicted to disrupt binding [4, 5] and 132 variants surrounding SNPs in NF-B related candidate genes that were previously associated with EOC risk [6] as custom content. We also included 2,000 of the most significantly associated variants from an unpublished GWAS among 1,452 endometrioid EOC cases.
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